• 'The numbers don't lie': Endoscopy to become more prominent among next generation of spine surgeons
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon killed in Oklahoma hospital shooting
  • Neurosurgeon accepted $3.3M in illegal payments to perform spine surgeries at hospital
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Texas spine surgeon defending himself from 'Dr. Death 2.0' allegations
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • 22 hospitals ranked top 25 orthopedic hospitals 3+ years in a row
  • Orthopedic surgeon convicted of battery at hospital
  • UArizona neurosurgery chair dies after motorcycle collision
  • America's largest independent practices by number of spine surgeons
  • Could Medtronic's spine business be the next medtech spinoff?
  • 41 'rising stars' in orthopedics
  • Idaho orthopedic surgeon arrested for alleged misconduct at practice
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Orthopedic surgeon salaries in the 5 best, worst states for healthcare
  • New Jersey hospital must pay neurosurgeons $24.3M, appeals court rules
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Why private equity is bettering orthopedics, 3 physician leaders say
  • Florida hospital patients say they were injured during surgeries. Now a physician faces 350 lawsuits.
  • Texas spine surgeon's $11M verdict being appealed
  • A Rutgers physician accused of 'ghost surgeries' will return — but with fewer responsibilities
  • Top orthopedic hospital in every state: US News
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • Unnecessary spine cases spur class action lawsuit
  • Colorado Supreme Court rejects hospital's bid to enforce $229K spine surgery bill
  • Jury finds neurosurgeon largely responsible for paralysis, awards $15.5M in damages
  • Dr. Jon Yoon performs NHL's 4th disc replacement in 7 months
  • 'Even my customers were upset': Stryker acquired Mako amid criticism and now the investment in robotics is paying off

    'Even my customers were upset': Stryker acquired Mako amid criticism and now the investment in robotics is paying off

    Laura Dyrda -  

    Stryker CEO Kevin Lobo talked about the company's robotics strategy and the decision to acquire Mako Surgical early, which propelled the company to become a market leader in orthopedic robotics, in a Chief Executive report.

    Mr. Lobo said the $1.65 billion deal for Mako Surgical was among the most controversial deals Stryker has ever done; it was also his first big deal leading the company. "Even my customers were upset, it was a disruptive idea," Mr. Lobo said in the report. "Most of the deals we do are simple tuck-in products, they're obvious. It's a need that we have, we fill the gap. This was disruptive."

    At the time, Mr. Lobo said customers and consultants told him when the deal was made in 2013 that robotics wasn't needed in orthopedic surgery, and they didn't want the technology. However, Mr. Lobo made the purchase with a keen eye for the future. He saw that the future of knee surgery would depend on how well the knee is balanced and minimal disruption to the soft tissue, not the implant; robotics could provide the next level of care with 3D planning technology and the ability to create a more personalized procedure.

    When Stryker revealed the deal, its stock price dropped 5 percent and the company faced stark criticism. However, the market and tolerance for robotics in orthopedics has changed, and Mr. Lobo said there are now around 800 Mako robots being used, with about one of three knee surgeries being done with the robot.

    Now, Stryker sees its robotics offering as integral to its strategy to maintain market share.

    "Two of our competitors launched new knees three or four years ago, and we're taking market share from them with an older knee. Why? Because instead of investing in a new knee, we chose to invest in robotics to help put the knee in perfect balance, and we chose to invest in one component of the knee that's 3D printed so that you don't need to use bone cement when you do the procedure."

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Webinars

    Featured Podcast

    Featured Whitepapers